visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Access Pharmaceuticals, Inc.

    Get Full Access

    Description

    • Abeona Therapeutics Inc. (NASDAQ: $ABEO), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases.Abeona was forged from the companys close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases.Abeona's lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). Abeona is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), EB-201 for epidermolysis bullosa (EB), ABO-301 (AAV-FANCC) for Fanconi anemia (FA) disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. In addition, Abeona has a plasma-based protein therapy pipeline, including SDF Alpha (alpha-1 protease inhibitor) for inherited COPD, using its proprietary SDF (Salt Diafiltration) ethanol-free process. For more information, visit www.abeonatherapeutics.com
    • location

      Headquarters:3333 Lee Parkway Suite 600, Dallas, Texas, United States

      More
    • Access Pharmaceuticals, Inc. phone

      Phone Number: +1 214-905-5100

    • Access Pharmaceuticals, Inc. website

      Website:

    • Access Pharmaceuticals, Inc. employees

      Employees:4

    • Access Pharmaceuticals, Inc. revenue

      Revenue:$1 - 10M

    • Access Pharmaceuticals, Inc. legal name

      Legal Name:Access Pharmaceuticals, Inc.

    • Access Pharmaceuticals, Inc.'s Social Media

      Access Pharmaceuticals, Inc. linkedin Access Pharmaceuticals, Inc. facebook Access Pharmaceuticals, Inc. twitter
    • done Is this data correct?

    • |  NAICS Code: 325412  |

      Show More
    Person level website identification

    for Access Pharmaceuticals, Inc.

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Frequently Asked Questions regarding Access Pharmaceuticals, Inc.

    • Where are Access Pharmaceuticals, Inc.'s Headquarters?

      Access Pharmaceuticals, Inc.'s Headquarters are in 3333 Lee Parkway Suite 600,Dallas,Texas,United States

    • What is Access Pharmaceuticals, Inc.'s phone number?

      Access Pharmaceuticals, Inc.'s phone number is +1 214-905-5100

    • What is Access Pharmaceuticals, Inc.'s Revenue?

      Access Pharmaceuticals, Inc.'s revenue is $1 - 10M

    • What is Access Pharmaceuticals, Inc.'s NAICS code?

      Access Pharmaceuticals, Inc.'s NAICS code is 325412

    • How many employees are working in Access Pharmaceuticals, Inc.

      Access Pharmaceuticals, Inc. has 4 employees

    • What is Access Pharmaceuticals, Inc.'s Industry?

      Access Pharmaceuticals, Inc. is in the industry of Pharmaceuticals

    Company Directory